Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
Sponsor: International Peace Maternity and Child Health Hospital
Summary
It is intended to examine the short-term and long-term efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms born at 28 weeks and below. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.
Official title: The Short-term and Long-term Effects of IVIG for Bronchopulmonary Dysplasia in Preterm Infant Born at 28 Weeks and Below
Key Details
Gender
All
Age Range
1 Day - 10 Weeks
Study Type
INTERVENTIONAL
Enrollment
29
Start Date
2026-04-23
Completion Date
2029-09
Last Updated
2026-07-23
Healthy Volunteers
Yes
Conditions
Interventions
intravenous immunoglobulin
1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.
Locations (1)
International Peace Maternity and Child Health Hospital
Shanghai, China